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ABSTRACT: RebC is a putative flavin hydroxylase functioning together with RebP to carry out a key step
in the biosynthesis of rebeccamycin. To probe the mechanism of flavin-based chemistry in RebC, we
solved the structure of RebC with reduced flavin. Upon flavin reduction, the RebC crystal undergoes a
change in its unit cell dimension concurrent with a 5 Å movement of the isoalloxazine ring, positioning
the flavin ring adjacent to the substrate-binding pocket. Additionally, a disordered helix becomes ordered
upon flavin reduction, closing off one side of the substrate-binding pocket. This structure, along with
previously reported structures, increases our understanding of the RebC enzyme mechanism, indicating
that either the reduction of the flavin itself or binding of substrate is sufficient to drive major conformational
changes in RebC to generate a closed active site. Our finding that flavin reduction seals the active site
such that substrate cannot enter suggests that our reduced flavin RebC structure is off-pathway and that
substrate binding is likely to precede flavin reduction during catalysis. Along with kinetic data presented
here, these structures suggest that the first cycle of catalysis in RebC may resemble that of p-
hydroxybenzoate hydroxylase, with substrate binding promoting flavin reduction.
Rebeccamycin, a human DNA-topoisomerase I inhibitor,
is a natural product generated in the bacterium LecheValieria
aerocolonigenes by the action of eight enzymes: RebF,
RebH, RebO, RebD, RebP, RebC, RebG, and RebM (1-3).
While some Reb enzymes function alone to catalyze discrete
steps in the biosynthetic pathway, others function in pairs.
Although a complex has not yet been detected experimentally
between the two proteins, RebC is required together with
RebP, a cytochrome P450 enzyme, to generate the rebecca-
mycin aglycon from chlorinated chromopyrrolic acid (3) (a
net 8-electron oxidation). Because two proteins are required
for this conversion, it was unclear from initial studies if RebC
played a catalytic role in this process or simply served to
modify the activity of RebP. The puzzle arose from the
observation that small amounts of product are produced in
the absence of RebC when StaP, a close RebP homologue,
is used in place of RebP (4). This finding suggests that StaP
and its homologues are capable of performing all of the
necessary chemistry for aglycon formation. In contrast,
the addition of RebC to a reaction mixture eliminates the
production of side products and promotes the production of
the desired product (Figure 1) (4), indicating a role for RebC
as an modifying factor. However, recent work suggests that
StaP does not produce product directly but rather produces
a reactive intermediate that spontaneously forms some
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FIGURE 1: Reaction scheme for StaP- (a close homologue of RebP)
and RebC-mediated production of the dechloro rebeccamycin
aglycon, arcyriaflavin A 6, from chromopyrrolic acid 1. StaP alone
generates a mixture of products (K252c 4, 7-OH-K252c 5, and
arcyriaflavin A 6). By contrast, a single product, arcyriaflavin A 6,
is produced from chromopyrrolic acid 1 by the action of StaP and
RebC together. Aryl-aryl coupled chromopyrrolic acid 2 or 7-car-
boxy-K252c 3 are proposed products of StaP (5, 6).
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product over time (5). When RebC is present, this reactive
intermediate is sequestered in the RebC active site, prevent-
ing its decomposition, and is then converted enzymatically
to the rebeccamycin aglycon (5, 6). Specifically, RebC is
thought to be a flavin-dependent hydroxylase that reacts with
putative substrates, aryl-aryl coupled chromopyrrolic acid 2
and/or 7-carboxy-K252c 3, produced by the RebP homologue
StaP (5-7). Given the reactivity of both molecules, however,
the ability of either to act as a RebC substrate is difficult to
test directly (5).1
Due to the instability of the putative substrate molecule(s),
we have chosen a largely crystallographic approach to study
RebC, publishing three crystal structures prior to this work
(6). These RebC structures include a substrate-free form, a
structure with a tautomer of 7-carboxy-K252c 3 bound in
the active site, and a structure with K252c 4 bound in the
active site (Table 1). These structures show that RebC is
structurally homologous to members of the flavin-dependent
hydroxylase family (8-11) such as the well-studied p-
hydroxybenzoate hydroxylase (pHBH) (12). A comparison
of substrate-free and bound structures of RebC shows that
the binding of molecules into the active site elicits a change
in residues 354-363. These residues, which are adjacent to
the substrate-binding pocket, are disordered in the substrate-
free structure and become ordered as part of a helix in the
two structures with bound indolocarbazoles (Table 1). This
helix, including residues 354-363, is termed the “melting
helix”, reflecting its ability to change states (ordered or
disordered) depending on the conditions. The melting of this
helix is thought provide the route by which substrates enter
and products depart the active site (6). The presence of a
“melting helix” contrasts with its structural homologue,
p-hydroxybenzoate hydroxylase, which uses a third confor-
mation of the flavin, an OPEN conformation, to enable entry
to the active site (13).
Structural comparisons also show that the FAD can adopt
two conformations in RebC: an OUT conformation in which
the isoalloxazine of FAD is more solvent accessible and an
IN conformation where the isoalloxazine is more secluded
from solvent and positioned to interact with bound substrate-
like molecules. pHBH also utilizes a “mobile flavin” in its
reaction mechanism (8). Interestingly, not all substrate-like
molecules elicit a change in FAD conformation from OUT
to IN in RebC. The isoalloxazine of FAD is IN in the
structure with 7-carboxy-K252c 3 bound but is OUT when
K252c 4 is bound. This difference in observed FAD
conformation may reflect the fact that 7-carboxy-K252c 3
is, or more closely resembles, the true substrate of RebC.
While K252c 4 is known not to be a substrate (4), 7-carboxy-
K252c 3 is too reactive to be tested conveniently as a possible
substrate (5). We were only able to obtain the structure of
7-carboxy-K252c 3 bound RebC by soaking crystals in a
mixture of chromopyrrolic acid 1 degradation products for
a week. Over this time period, 7-carboxy-K252c 3 selectively
accumulates in the active site of crystallized RebC, allowing
for its structural characterization. This selectivity of RebC
for 7-carboxy-K252c 3 over a mixture of chromopyrrolic
acid degradation products is consistent with the idea that
7-carboxy-K252c 3 may closely resemble or be the RebC
substrate.
1 Abbreviations: FAD, flavin adenine dinucleotide; FADH-, reduced
flavin adenine dinucleotide; tautomer of 7-carboxy-K252c 3, 7-carboxy-
5-hydroxy-12,13-dihydro-5H-indolo[2,3-a]pyrrolo[3,4-c]carbazole; aryl-
aryl-coupled chromopyrrolic acid 2, 5,7-dicarboxy-12,13-dihydro-5H-
indolo[2,3-a]pyrrolo[3,4-c]carbazole; K252c 4, 6,7,12,13-tetrahydro-
5H-indolo[2,3-a]pyrrolo[3,4-c]carbazol-5-one; 7-hydroxy-K252c 5, 7-
hydroxy-6,12,13-trihydro-5H-indolo[2,3-a]pyrrolo[3,4-c]carbazole; ar-
cyriaflavin A 6, 12,13-dihydro-5H-indolo[2,3-a]pyrrolo[3,4-c]carbazole-
5,7(6H)-dione; pHBH, p-hydroxybenzoate hydroxylase; pOHB, p-hy-
droxybenzoate.
Table 1: Available Structures of RebC
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Like the FAD in RebC, the isoalloxazine in pHBH shifts
to an IN conformation when substrate is bound. Substrate
binding to pHBH also dramatically affects the rate of
reduction of the FAD by NADPH. When NADPH binds to
a pHBH-pOHB complex, spectral shifts indicate that the
FAD moves from IN to OUT, positioned for the N5 of the
isoalloxazine to accept a hydride from NADPH. Upon FAD
reduction, crystallographic data tell us that the FADH- of
pHBH moves back to an IN conformation where it can react
with molecular oxygen and substrate. To examine the
structural effect of FAD reduction in RebC, we have
determined the structure of RebC with fully reduced flavin.
Although we do not know the protonation state of reduced
flavin from our structure, we will assume in this report that
it is FADH-, and not FADH2, consistent with the typical
protonation state of FAD in this family of proteins (14, 15).
Here we find reduced flavin in RebC in an IN conformation,
with the “melting helix” ordered. This structure, which we
will call the “reduced-RebC” structure, is very similar to the
structure of RebC with a bound tautomer of putative substrate
7-carboxy-K252c 3, suggesting that either reduction of the
flavin or appropriate positioning of a carboxylate-containing
substrate such as the tautomer of 7-carboxy-K252c 3 is
sufficient to trigger the movement of the isoalloxazine to
the IN position and to cause the “melting helix” to form,
sealing off the substrate-binding pocket. We have also
examined the rate of reduction of FAD in RebC by NADH
in the absence of substrate and find that like pHBH the rate
is slow. These new findings, along with the previous
structural work on RebC, allow for a detailed comparison
of putative flavin hydroxylase RebC with pHBH, one of the
better studied family members.
MATERIALS AND METHODS
Sample Preparation. RebC protein was prepared and
crystallized as described earlier (4, 6). Reduced RebC was
generated by incubating a RebC crystal in a cryogenic
solution (19% PEG-8000, 0.1 M HEPES, pH 7.4, 20%
glycerol) and adding an amount of solid sodium dithionite
that is in slight excess of the point at which the crystal
became completely clear, indicating that all FAD was
reduced. The crystal was then flash-frozen in liquid nitrogen.
Data Collection and Processing and Structure Determi-
nation. Data were collected at beamline 9-2 at the Stanford
Synchrotron Radiation Laboratory, integrated in HKL2000,
and scaled in Scalepack (16) without σ cutoff. The unit cell
volume of reduced RebC is 602000 Å3, almost twice the
volume of substrate-free RebC, because two monomers
previously related by a crystallographic 180° rotation shift
to be related by a 160° rotation, with consequent alteration
of the a, c, and  values of the unit cell (Table 1). Data
collection statistics are shown in Table 2. The structure of
reduced RebC was solved in CNS (17), using rigid-body
refinement and the coordinates from PDB ID 2R0G, with
reflections flagged as “free” identically to the structure factor
file used in refinement of PDB ID 2R0G. Only coordinates
for protein atoms were used in rigid-body refinement, with
coordinates for water molecules and flavin molecules added
later in refinement. Following rigid-body refinement, multiple
rounds of refinement, including simulated annealing, were
carried out in CNS with alternate rounds of manual adjust-
ment carried out in COOT (18). We found no notable
differences between the two molecules of RebC in the
asymmetric unit, regardless of whether or not noncrystallo-
graphic symmetry (NCS) restraints were used. However, to
improve the data to parameter ratio, NCS restraints were used
throughout refinement. The topology and parameter files for
reduced flavin were generated from the FADH2 molecule in
the PrnA structure (PDB ID 2ARD) (19) as well as a higher
resolution FAD molecule from cholosterol oxidase (PDB ID
1N4V) (20), using XPLO2D (21). A composite omit map
was used to verify the overall structure, with omit maps also
generated for the flavin cofactor and the “melting helix”.
There are two protein chains in the asymmetric unit, each
containing 529 residues from RebC with 20 amino acids in
an N-terminal tag. RebC residues 3-529 from chain A and
2-529 from chain B are included in the final model, with
residues 247-250 and 417-423 disordered in chain A and
residues 247-250 and 418-421 disordered in chain B. There
is also one molecule of reduced flavin in each active site.
One sodium atom, positioned near an aspartate, was included
in the model. When instead modeled as water, its B-factor
was atypically low (5 Å2). More residues are outside of the
“most favored” region of a Ramachandran plot than has been
observed for other RebC structures (6); this is likely a
reflection of the lower resolution of these data relative to
Table 2: Data Collection and Refinement Statistics for the
Reduced-RebC Structure
Data Collection
beamline SSRL, 9-2
wavelength (Å) 0.9797
space group P21
unit cell
a, b, c (Å) 63.3, 78.2, 123.1
 (deg) 98.7
resolution (Å)a 40.0-2.97 (3.08-2.97)
completeness (%)a 90.4 (50.7)
I/σIa 9.9 (3.0)
redundancya 4.1 (3.1)
unique reflections 22485 (1255)
Rsyma,b 0.149 (0.270)
Refinement
resolution range (Å) 40.0-2.97
Rcryst (%)c 22.5
Rfree (%)c 27.6
no. of non-hydrogen atoms
protein 7913
FADH- 106
water 65
Na+ 1
average B-factors (Å2)
protein 46.7
FADH- 38.6
water 23.4
Na+ 23.6
rmsdd bond length (Å) 0.008
rmsdd bond angle (deg) 1.34
Ramachandran plot (% residues)
most favored 85.2
additionally allowed 14.1
generously allowed 0.5
disallowed 0.2
a Values in parentheses indicate highest resolution bin. b Rsym )
(∑i∑hkl|Ii(hkl) - 〈I(hkl)〉|)/∑hkl〈I(hkl)〉, where Ii(hkl) is the intensity of the
ith measured reflection and 〈I(hkl)〉 is the mean intensity for the
reflection with the Miller index (hkl). c Rcryst ) (∑hkl||Fo(hkl)| -|Fc(hkl)||)/∑hkl|Fo(hkl)|; Rfree is calculated identically, using 5% of ref-
lections omitted from refinement. d Root mean squared deviation.
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other RebC structures (Table 1). Refinement statistics for
the reduced-RebC structure are shown in Table 2.
Analysis of Surface Accessibility of the Substrate-Binding
Pocket. CAVER (22) was used to determine if any pathways
connected the substrate-binding pocket of RebC to external
solvent, with subsequent examination of results in PYMOL
(http://pymol.sourceforge.net). Based on the representation
of this pathway as spheres with varying radii, the widest
pathway identified that leads to solvent in the reduced-RebC
structure is too narrow for a putative RebC substrate to
traverse.
Determination of Rate Constant for Reduction of FAD in
the Absence of Substrate under Single TurnoVer Conditions.
RebC was diluted in 150 mM NaCl, 10% glycerol, and 25
mM HEPES, pH 7.5, in a glass tonometer and made
anaerobic by∼15 alternate cycles of incubation with purified
argon gas and purging by vacuum. 3,4-Dihydroxybenzoate
and protocatechuate 3,4-dioxygenase were included to scav-
enge any residual oxygen (23). A stock solution of 13 mM
NADH was prepared in unneutralized Tris base, and dilutions
were made into the RebC buffer (150 mM NaCl, 10%
glycerol, 25 mM HEPES, pH 7.5). All NADH solutions were
bubbled with argon for >15 min prior to use. A Hi-Tech
DX-2 stopped-flow spectrophotometer (Bradford on Avon,
U.K.) was incubated with an anaerobic solution of 3,4-
dihydroxybenzoate and protocatechuate 3,4-dioxygenase
overnight prior to use. The tonometer containing the enzyme
was connected to one syringe and the buffer or NADH
solution was connected to the second syringe of the stopped-
flow spectrophotometer. Detection was with a photomulti-
plier, and spectra were recorded at approximately 5 min
intervals. Data were analyzed using KinetAsyst 3.16.
RESULTS
Unit Cell Dimensions Change. RebC crystals grown from
recombinantly expressed and purified protein have unit cell
dimensions of a ) 63.2 Å, b ) 77.6 Å, c ) 64.7 Å, and 
) 108.0° (space group P21) with one monomer per asym-
metric unit (PDB ID 2R0C) and appear yellow throughout
data collection (6). However, upon incubation of these
crystals with dithionite, the crystals lose their yellow color
and assume alternate unit cell dimensions of a ) 63.3 Å, b
) 78.2 Å, c ) 123.1 Å, and  ) 98.7° (space group P21)
with two monomers per asymmetric unit. The cell dimension
change occurs when two chains, previously related by a
crystallographic 180° rotation, shift relative positions such
that they are related by a 160° rotation. The unit cell
dimensions of the sodium dithionite-reduced crystals are
similar to the unit cell dimensions observed from RebC with
a bound tautomer of 7-carboxy-K252c 3 (PDB ID 2R0G),
which also changes cell dimensions relative to the substrate-
free structure and has unit cell dimensions of a ) 64.9 Å, b
) 78.4 Å, c ) 123.6 Å, and  ) 99.6° (space group P21)
(6). Unlike the RebC crystals with a bound tautomer of
7-carboxy-K252c 3, however, which diffracted to 2.4 Å
resolution (6), sodium dithionite-soaked RebC crystals gener-
ally gave poorer quality data, with the best data obtained
reported here (2.97 Å resolution). The change in unit cell
dimensions must occur over a short period of time (less than
a few minutes) in the case of sodium dithionite soaking of
RebC, whereas the accumulation of the tautomer of 7-car-
boxy-K252c 3 in the active site of RebC takes much longer
(an entire week) (6). It is possible that the rapid change in
unit cell dimensions caused by soaking in the presence of
sodium dithionite resulted in the lower quality data achieved
for the reduced-RebC structure compared to the structure of
RebC with a bound tautomer of 7-carboxy-K252c 3 (Table
1).
The FAD Cofactor MoVes IN upon Reduction. The
similarities of the reduced-RebC structure to that of FAD-
RebC with a bound tautomer of 7-carboxy-K252c 3 extend
to the positioning of the isoalloxazine in the active site. In
the structure of FAD-RebC with a bound tautomer of
7-carboxy-K252c 3, the FAD is observed in the IN confor-
mation, adjacent to the bound molecule in the substrate-
binding pocket. Likewise, the reduced flavin in the reduced-
RebC structure is also observed in the IN conformation
(Supporting Information Figure 1). The positioning of the
cofactor in the reduced-RebC structure and in the structure
of FAD-RebC in complex with a tautomer of 7-carboxy-
K252c 3 is different from the substrate-free and K252c
4-soaked structures, where the FAD is observed in the OUT
conformation (Table 1, Figure 2A). Hence, after reduction
by dithionite, the reduced isoalloxazine of the flavin cofactor
moves approximately 5 Å on the pivot of the pyrophosphate
phosphate moiety proximal to the flavin from the OUT to
the IN position (Figure 2A, Supporting Information Figure
2).
The OVerall Structure Is Highly Similar to the Structure
of RebC with a Bound Tautomer of 7-Carboxy-K252c. The
root mean squared deviation (rmsd) distance between the
reduced-RebC and structure of RebC with a bound tautomer
of 7-carboxy-K252c 3 is 0.66 Å for 514 CR carbon atoms.
By comparison, the rmsd variations in distances between the
reduced RebC and FAD-RebC with bound K252c 4 structure
is 0.82 Å for 504 CR carbon atoms, and the rmsd between
the reduced RebC and the FAD-RebC substrate-free structure
is 1.02 Å for 494 CR carbon atoms. The active sites
themselves of the reduced-RebC structure and structure of
FAD-RebC with a bound tautomer of 7-carboxy-K252c 3
also are nearly superimposable, with one key exception: no
substrate molecule is bound in the reduced-RebC structure
(Figure 2C,D). Interestingly, even the “melting helix”, a helix
that is disordered in the substrate-free structure, which
becomes ordered in the structures of RebC with bound K252c
4 and with the bound tautomer of 7-carboxy-K252c 3 (Figure
2F), also becomes ordered in reduced RebC, despite the lack
of a substrate-like molecule in the substrate-binding pocket
(Figure 2B,E, Supporting Information Figure 3).
The Substrate-Binding Pocket Is Inaccessible to Substrate
upon FlaVin Reduction. To determine if an indolocarbazole-
like substrate could enter the binding pocket in a reduced-
RebC state, the program CAVER was used (22) to identify
the favored path by which a probe placed in the active site
would escape to the solvent. The four available structures
of RebC (2R0C, 2R0G, 2R0P, and 3EPT, the reduced-RebC
structure presented here) were analyzed, with bound mol-
ecules in the active site removed for 2R0G and 2R0P. The
substrate-free RebC structure (2R0C) showed the most
solvent accessible pathway, with a probe placed in the active
site moving immediately to the solvent, via the disordered,
“melted helix”, between residues 354-363 (Figure 3A,B).
By contrast, for the other three structures, each of which
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contains a formed helix between residues 354-363 (Figure
3C,D), the pathway from the substrate-binding site to external
solvent is via another side of the active site (Figure 3E).
However, based on examination of the results in PYMOL,
this pathway is unlikely to be wide enough near the active
site for an indolocarbazole-like molecule to traverse to the
surface of the enzyme (Figure 3E,F). This pathway is also
the widest route to the substrate-binding site from the surface
of the protein in the reduced-RebC structure. We suggest
that an indolocarbazole-sized molecule would require an
opening with a radius of at least 4.5 Å; however, the pathway
out of the reduced-RebC structure from where a substrate
would be positioned does not become 4.5 Å wide until just
before the surface of the enzyme.
Reduction of RebC Is Slow in the Absence of Substrate.
Previous studies have shown that NADH is the preferred
reductant for RebC in the two-enzyme conversion of chro-
mopyrrolic acid 1 to arcyriaflavin A 6 (4). To investigate
the rate constant of reduction of the FAD in RebC by NADH,
we used a stopped-flow spectrophotometer and analyzed the
reduction of FAD (by monitoring A450). Reduction was
extremely slow, and in retrospect, the use of a stopped-flow
spectrophotometer to determine the rate constant was un-
necessary. However, using an extremely high concentration
of NADH (1 mM), the rate constant for reduction was
determined as 0.0023 s-1 (Supporting Information Table 1),
an extremely slow rate.
DISCUSSION
Our structure of reduced-RebC provides insight into the
catalytic cycle of RebC. The structure of reduced RebC
contains flavin in an IN conformation and contains an ordered
FIGURE 2: Structural comparisons between reduced-RebC and other
RebC structures. (A) Reduced flavin from the reduced-RebC
structure (this work) is shown with magenta carbons, FAD from
the substrate-free structure (PDB ID 2R0C) is shown with blue
carbons, and FAD from the structure of RebC with a bound
tautomer of 7-carboxy-K252c 3 (PDB ID 2R0G) is shown with
green carbons. Top: Reduced flavin from the reduced-RebC
structure superimposed with FAD from the substrate-free structure.
Bottom: Reduced flavin from the reduced-RebC structure super-
imposed with FAD from the RebC structure with a bound tautomer
of 7-carboxy-K252c 3. (B) Structure of reduced-RebC colored red
(domain I, cofactor-binding domain), blue (domain II, base of
substrate-binding pocket), and green (domain III, thioredoxin-like
domain). Blue composite omit density is contoured at 1.4σ around
the reduced flavin molecule (see Supporting Information Figure 1
for stereoviews). Arrows indicate the boundaries of the “melting
helix”, which is ordered in this structure (see Supporting Information
Figure 3 for omit density of melting helix). (C) Active site of the
reduced-RebC structure, with dashes indicating hydrogen-bonding
interactions. (D) Active site of RebC with a bound tautomer of
7-carboxy-K252c 3 (PDB ID 2R0G) with dashes indicating
hydrogen-bonding interactions. (E) The “melting helix” from the
reduced-RebC structure is shown with side-chain atoms as sticks,
with leucine-358 labeled. (F) The “melting helix” from the RebC
structure with a bound tautomer of 7-carboxy-K252c 3 (PDB ID
2R0G) is shown with side-chain atoms as sticks. Leucine-358 is
less than 4 Å from the bound tautomer of 7-carboxy-K252c 3.
FIGURE 3: Access to the substrate-binding pocket. (A) In the
substrate-free structure of RebC, residues 354-363 of the “melting
helix” are disordered. The boundaries of this region are shown in
red. FAD is shown with blue sticks. (B) Surface representation of
the structure in (A). Part of the FAD molecule (blue sticks) can be
seen inside the structure. (C) An identical view of the reduced-
RebC structure with the “melting helix” in red. (D) Surface
representation of the reduced-RebC structure shown in (B). (E) With
the “melting helix” ordered a pathway traced to external solvent
from the active site of reduced RebC. Protein is in gray with the
surface traced. Flavin is depicted in thick blue sticks, and the
pathway is shown with red spheres. (F) The same pathway can be
traced from the active site of the structure of RebC with a bound
tautomer of 7-carboxy-K252c 3 and the “melting helix” ordered.
The protein surface is shown in pale green, with the tautomer of
7-carboxy-K252c 3 shown in red. This entryway to the substrate-
binding site is likely too narrow for a substrate-like molecule to
traverse.
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helix adjacent to the substrate-binding pocket. Substrate-free
RebC, by contrast, which was used to generate the reduced
RebC by soaking with a dithionite solution, has flavin in an
OUT conformation and a disordered, “melting helix”. Thus,
reduction of the cofactor causes the isoalloxazine to move
IN and the “melting helix” to become ordered. Together with
another structure of RebC, that of RebC with a bound
tautomer of 7-carboxy-K252c 3, where flavin is IN and the
“melting helix” is ordered, we now have several crystal-
lographic “snapshots” of this interesting enzyme (Tables 1
and 4). One structure we do not yet have is that of reduced
RebC with a bound tautomer of 7-carboxy-K252c 3. Obtain-
ing such a structure may be difficult given that both steps
involved, the week-long soak with chromopyrrolic acid 1
and reduction with dithionite, lead to significant losses in
resolution. Although we do not have a structure of reduced-
RebC with a bound tautomer of 7-carboxy-K252c 3, we
expect that such a structure would be nearly identical to the
structure of FAD-RebC with a bound tautomer of 7-carboxy-
K252c 3, given that flavin reduction and substrate binding
each bring about similar conformational changes in RebC.
Despite these various crystallographic “snapshots” of
RebC, questions remain about the mechanism of RebC,
largely because its putative substrates are too reactive for
convenient enzymatic study. Hypothetical reaction schemes
of RebC with putative substrates 7-carboxy-K252c 3 or aryl-
aryl coupled chromopyrrolic acid 2 suggest that RebC may
have to carry out multiple rounds of oxidative chemistry to
generate the rebeccamycin aglycon, but few wild-type flavin
hydroxylases are capable of doing multiple rounds of flavin-
based catalytic chemistry on a single substrate molecule. One
interesting enzyme to compare with RebC might be salicylate
hydroxylase, which catalyzes both hydroxylation and decar-
boxylation reactions of its substrate (7, 24); however, many
mechanistic details are lacking for this enzyme. In any case,
the possibility that RebC, like other flavin hydroxylases,
carries out only one round of catalysis on its substrate is
still a reasonable hypothesis if the remainder of the chemistry
is spontaneous in aerobic conditions and results in only the
desired final product. Because of the many unknowns in the
catalytic cycle of RebC, it makes sense to think about a single
round of catalysis in comparison to the best studied flavin
hydroxylase enzyme, p-hydroxybenzoate hydroxylase.
p-Hydroxybenzoate hydroxylase, the canonical flavin-
dependent hydroxylase, is thought to carry out a flavin-based
hydroxylation of its substrate through at least seven states
(Supporting Information Figure 4). The details of these states
have been elucidated using a combination of stopped-flow
spectroscopy and X-ray crystallography (Table 3). In brief,
pHBH, initially existing with oxidized flavin in a dynamic
equilibrium between the OPEN and IN positions (state 1),
captures a molecule of p-hydroxybenzoate (pOHB) while in
the OPEN conformation, an additional conformation of the
flavin that enables entry of substrate and departure of product
in pHBH (25). Substrate binding then shifts the equilibrium
of the isoalloxazine toward the IN conformation (state 2), a
state that is represented by one of the original structures of
pHBH, where pOHB was bound to pHBH (26). When
NADPH binds the enzyme containing bound pOHB, the
flavin is triggered to move to the OUT conformation (state
3) where the N5 of the isoalloxazine is positioned optimally
to receive a hydride from NADPH; this transition only occurs
when substrate is bound. Upon reduction of the FAD by
NADPH (state 4), NADP+ is released. The resultant FADH-
anion shifts to the IN position due to the positive electrostatic
field near the IN position (state 5); the structure of pHBH
with reduced flavin and bound substrate (obtained using
anoxygenic solutions) represents this state (27). Next, flavin
reacts with oxygen and hydroxylates the bound pOHB, while
in the IN conformation (states 6 and 7). Finally, the resulting
product, 2,3-dihydroxybenzoate, is released via the OPEN
conformation, and loss of H2O returns the FAD cofactor to
its oxidized form and pHBH to the initial state (state 1),
which is a dynamic equilibrium between the OPEN and IN
positions (12). Table 3 describes the experimental support
for each step of this scheme, including those states which
have been observed crystallographically.
Table 3: Experimental Evidence for States of p-Hydroxybenzoate Hydroxylase Catalytic Cycle
state
description of
state position of flavin crystallographically observed PDB ID biochemical evidence
1 substrate-free OPEN-IN equilibrium yes, but as R220Q mutant 1K0L (13) slow substrate binding but otherwise
unchanged catalysis of E49N
mutant suggests two
interconverting states (29); R220Q
mutant more stable in OPEN than
IN state (25); single molecule
studies on substrate-free pHBH
(30)
2 substrate-bound IN yes 1PBE (26)
3 substrate-bound,
NADPH-bound
transition to OUT no, but R220Q mutant observed
with NADPH (no substrate) and
wild type with alternate substrate
observed in OUT conformation
1K0J (13), 1DOD (8, 28) spectral shifts on flavin movement
to the OUT position; R220K
mutant stabilized in OUT
conformation (31)
4 substrate-bound,
FADH-,
NADP+-bound
OUT no, but R220Q mutant observed
with NADPH (no substrate)
1K0J (13)
5 substrate-bound,
FADH-
IN yes not deposited (27) movement of reduced flavin to IN
conformation driven by positive
electrostatic field as shown by
K297M mutant (15)
6 substrate-bound,
flavin-C4a-O-OH
IN no observed spectroscopically (32)
7 product bound,
flavin-C4a-OH
transition to OPEN yes, but with product bound, FAD
complex
1PHH (33) observed spectroscopically (32)
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Our crystallographic observations have collectively cap-
tured three states of RebC. Using the known reaction
mechanism for pHBH, we can begin to piece together a likely
reaction cycle for one round of flavin-based hydroxylation
in RebC (Table 4). The first state we have captured is state
1, prior to substrate binding. In this stage, the flavin is OUT
and the “melting helix” is disordered. In contrast to pHBH,
where a third conformation of the flavin, the OPEN
conformation, is thought to enable entry of substrate and
departure of product, in RebC, we believe the “melting helix”
is instead the route for substrate entry and product departure.
Unlike p-hydroxybenzoate, the putative RebC substrate is
too large to enter the active site through a flavin OPEN
conformation. Additionally, in contrast to the flavin in pHBH,
the RebC flavin is OUT prior to substrate binding. The
second state we have captured is a state 2 conformation,
where substrate is bound. In this state, the flavin is IN (as is
true in pHBH) and the “melting helix” is ordered. The third
state we have captured is likely off-pathway, having bound
reduced flavin but no bound substrate. This structure is
suggestive of a state 5-like conformation, where flavin is
reduced and substrate is bound. Although there is no substrate
bound in this structure, the “melting helix” is ordered, and
substrate would be unable to enter. Therefore, although no
actual substrate molecule is present in this structure, RebC
appears to assume a conformation as though a substrate
molecule were bound; i.e., this reduced-RebC structure seems
to represent a stage in the catalytic cycle where substrate is
bound adjacent to reduced flavin. Overall, our structural
investigation of RebC has revealed two major similarities
with the p-hydroxybenzoate hydroxylase catalytic cycle: there
is a mobile flavin, and the flavin moves IN upon reduction.
There are also two key differences from the p-hydroxyben-
zoate hydroxylase catalytic cycle, based on our crystal-
lographic observations: (1) the displacement of the “melting
helix” appears to be the conduit for substrate entry and
departure, rather than an OPEN conformation of the flavin,
likely because of the larger size of RebC’s substrate(s), and
(2) prior to substrate binding, the FAD in RebC exists in an
OUT conformation, in contrast to the OPEN structure for
pHBH (26).
The most intriguing aspect of our reduced flavin structure
is the sealing of the “melting helix” without the presence of
a bound substrate-like molecule. While the ordering of the
helix in the presence of bound hydrophobic molecules can
be explained by hydrophobic interactions between the bound
molecules and protein residues, such as leucine-358 (Figure
2F), there are no direct contacts between the reduced flavin
and helix that can easily explain the ordering of the helix
upon change in the redox state of the cofactor and its
movement to the IN conformation (Figure 2E). One possible
explanation for helix ordering may be that the shift of the
flavin conformation drives desolvation, which in turn orders
the helix. However, due to the lower number of ordered
waters overall in this modest resolution structure, it is difficult
to assess this possibility from these structural data. While
the molecular explanation for this conformation change
remains elusive, the fact that the helix is formed after flavin
reduction is certainly suggestive of a key detail in the RebC
catalytic cycle: substrate must bind before flavin reduction.
Otherwise, flavin reduction will trigger helix formation and
substrate will not get in. Substrate binding occurring prior
to flavin reduction is also consistent with the p-hydroxyben-
zoate hydroxylase catalytic cycle, where substrate binding
causes a 100000-fold increase in the rate of NADPH
oxidation (12). Although the instability of the proposed RebC
substrates has so far prevented us from obtaining the
analogous data for RebC, we can compare the rate of FAD
reduction without substrate to the rate of overall turnover
for the coupled enzyme (StaP/RebC) system in the presence
of substrate. The kcat of the coupled enzyme system using
chromopyrrolic acid 1 is 0.068 ( 0.01 s-1 (4). This
experiment was carried out using a mixture including StaP
(1 µM), RebC (5 µM), NADH (5 mM), spinach ferredoxin
(20 µM), flavodoxin NADP+-reductase (1 µM), and FAD
(1.7 µM). This turnover rate, which includes reduction and
hydroxylation steps, is substantially greater than the rate for
FAD reduction of RebC by 1 mM NADH in the absence of
substrate (0.0023 s-1) (Supporting Information Table 1). This
comparison suggests that substrate binding to RebC must
accelerate the rate of flavin reduction by its preferred
reductant, NADH, by an order of magnitude. Together with
the structural data, this kinetic result suggests that reduction
of FAD in the absence of substrate resulting in the ordering
of the “melting helix” is unlikely to be physiological relevant
and points to a mechanism in which substrate binding to
RebC occurs first, ordering the “melting helix” and promoting
flavin reduction by NADH.
If the mechanism of RebC includes two hydroxylation
steps, one could imagine that the first hydroxylated inter-
mediate that is formed is held in place in the active site by
an ordered “melting helix”, while the newly reoxidized FAD
could swing OUT for rereduction by a second molecule of
NADH, in a step that might mimic state 3 of pHBH (8, 13, 28).
Only after the completion of the full reaction would product
be released. Regardless of the number of hydroxylation
events, the observation that one product is formed when
RebC is added to a StaP reaction mixture indicates that
accessibility of the active site of RebC must be tightly
controlled, and our structural studies suggest that the “melting
Table 4: Proposed States of the RebC Catalytic Cycle
state in
RebC catalytic
cycle description of state
position
of flavin
state of the
“melting” helix crystallographically observed PDB ID
1 substrate-free OUT disordered yes 2R0C
2 substrate-bound IN ordered yes 2R0G
3 substrate-bound, NADH-bound unknown unknown no
4 substrate-bound, FADH-, NAD+-bound unknown unknown no
5 substrate-bound, FADH- IN ordered no, but substrate-free reduced-RebC
structure is suggestive of IN conformation
3EPT
6 substrate-bound, flavin-C4a-O-OH unknown unknown no
7 product-bound, flavin-C4a-OH unknown unknown no
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helix” is critical to that control. While our structural and
kinetic studies show many similarities between RebC and
pHBH, we do find that RebC adaptations, such as the
“melting helix”, make it ideally suited to partner with a P450
enzyme, perhaps through a transient interaction during
catalysis, accepting and sequestering RebP’s reactive product
for the exclusive production of the rebeccamycin aglycon.
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